Canadian Contraception Consensus (Part 3 of 4): Chapter 8 - Progestin-Only Contraception.
To provide guidelines for health care providers on the use of contraceptive methods to prevent pregnancy and on the promotion of healthy sexuality.



Overall efficacy of cited contraceptive methods, assessing reduction in pregnancy rate, safety, ease of use, and side effects; the effect of cited contraceptive methods on sexual health and general well-being; and the relative cost and availability of cited contraceptive methods in Canada.



Published literature was retrieved through searches of Medline and The Cochrane Database from January 1994 to January 2015 using appropriate controlled vocabulary (e.g., contraception, sexuality, sexual health) and key words (e.g., contraception, family planning, hormonal contraception, emergency contraception). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies published in English from January 1994 to January 2015. Searches were updated on a regular basis in incorporated in the guideline to June 2015. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.



The quality of the evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table 1). CHAPTER 8: PROGESTIN-ONLY CONTRACEPTION: Summary Statements Recommendations.
Ottawa ON (Co-Chair).
Amanda
A
Black
Quebec QC (Co-Chair).
Edith
E
Guilbert
Hamilton ON.
Dustin
D
Costescu
Toronto ON.
Sheila
S
Dunn
London ON.
William
W
Fisher
Toronto ON.
Sari
S
Kives
Saskatoon SK.
Melissa
M
Mirosh
Vancouver BC.
Wendy
W
Norman
Winnipeg MB.
Helen
H
Pymar
Kingston ON.
Robert
R
Reid
Montréal QC.
Geneviève
G
Roy
Vancouver BC.
Hannah
H
Varto
Kingston ON.
Ashley
A
Waddington
Montréal QC.
Marie-Soleil
MS
Wagner
Halifax NS.
Anne Marie
AM
Whelan
D002170:Canada; D003267:Contraception; D005260:Female; D006801:Humans; D011247:Pregnancy; D011372:Progestins / Q000008:administration & dosage / Q000627:therapeutic use; D034121:Reproductive Health Services
D011372:Progestins
Canada; Contraception; barrier methods of contraception; contraceptive implants; depo-medroxyprogesterone acetate; emergency contraception; hormonal contraception; injectable contraception; progestin-only pill; sexual health; sexuality; statistics